West Virginia Attorney General Patrick Morrisey is urging the U.S. Justice Department to throw out a preliminary $465 million settlement with Mylan for overcharging Medicaid for the EpiPen, calling it “woefully deficient compared to the actual cost of Mylan’s fraud.”

In a letter Wednesday to U.S. Attorney General Loretta Lynch, Mr. Morrisey said the deal would cheat taxpayers who fund Medicaid and the states that participate in the program out of millions of dollars, alleging that Mylan may owe nearly $700 million to Medicaid.

Mylan has classified the EpiPen emergency allergy treatment as a generic instead of a brand name drug, allowing it to pay lower rebates to Medicaid. Drug companies are responsible for ensuring that their products are correctly classified.

Mylan announced the deal in early October, but the Justice Department has not said how the settlement figure was determined. Iowa Republican Sen. Chuck Grassley plans a Senate Judiciary Committee hearing on Nov. 30 seeking more details.

Advertise with us

Mr. Morrisey’s criticism follows a similar rebuke nearly two weeks ago by Sen. Elizabeth Warren, D-Mass., who blasted the settlement as “shamefully weak.”

The West Virginia attorney general disclosed in late August that his office was investigating Mylan over the Medicaid issue and whether the soaring price of the EpiPen in recent years violated antitrust laws. Mylan’s flagship manufacturing plant is in Morgantown, W.Va., while its operations base is in Cecil.

If the Justice Department finalizes the $465 million settlement, Mr. Morrisey is urging West Virginia’s Department of Health and Human Resources to opt out of the deal.

The Justice Department declined comment Wednesday on Mr. Morrisey’s letter. Mylan did not respond to emails seeking comment.

“Mylan must not be allowed to receive a windfall after flagrantly defrauding the Medicaid Drug Rebate program,” Mr. Morrisey said in his letter, adding that it would send the wrong message to other pharmaceutical companies engaged in “similar malfeasance.”

Advertise with us

Mylan’s settlement accord did not include an admission of wrongdoing.

Meanwhile, on Tuesday, Ms. Warren and 16 other U.S. senators sent a 12-page letter to Mylan asking for more information about EpiPen price increases.

The letter faulted Mylan’s response to a previous request, saying: “We remain frustrated with both the lack of information and lack of clarity … and your insistence that you are not aware of the basic facts about sales of your own drug to Medicaid and Medicare Part D recipients.”

Patricia Sabatini: PSabatini@post-gazette.com; 412-263-3066.